Trials / Unknown
UnknownNCT01268722
Balloon Angioplasty Versus Primary Stenting for the Treatment of Femoropopliteal Artery Chronic Total Occlusions
Balloon Angioplasty Versus Self-expanding Stent for Recanalization of Chronic Total Occlusions of the Femoral Artery
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- University of Patras · Academic / Other
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter double-arm randomized trial investigating plain balloon angioplasty versus primary placement of self-expanding nitinol stents after endovascular recanalization of femoral CTOs. Study will recruit up to 200 patients to be adequately powered for detection of a significant difference in vessel patency after 1 year.
Detailed description
Primary placement of new-generation nitinol stents compared to plain old balloon angioplasty has shown encouraging long-term results in the femoropopliteal artery. However, there is complete lack of data about performance of new-generation nitinol stents in the treatment of chronic total occlusions (CTO) of the Femoral artery. This is a multicenter double-arm randomized trial investigating plain balloon angioplasty versus primary placement of self-expanding nitinol stents after endovascular recanalization of femoral CTOs. Study will recruit up to 200 patients to be adequately powered for detection of a significant difference in vessel patency after 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Balloon angioplasty | This arm will include patients randomized to undergo the treatment of a chronic total occlusion of the femoropopliteal artery with the use of balloon angioplasty |
| DEVICE | Primary stenting | This arm will include patients randomized to undergo primary stenting of the femoropopliteal chronic total occlusion |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2013-12-01
- Completion
- 2016-12-01
- First posted
- 2010-12-31
- Last updated
- 2012-04-06
Locations
5 sites across 3 countries: Greece, Italy, United Kingdom
Source: ClinicalTrials.gov record NCT01268722. Inclusion in this directory is not an endorsement.